Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Immunomodulation via paracrine signaling by mesenchymal stem cells (MSCs) refers to the process by which MSCs influence immune responses not through direct cell-to-cell contact, but rather through the secretion of soluble factors and extracellular vesicles. These secreted products—collectively known as the MSC "secretome"—include cytokines, chemokines, growth factors, microRNAs (miRNAs), and exosomes that modulate inflammation, promote tissue repair, and regulate both innate and adaptive immune responses.
MSC secrete soluble factors and extracellular vesicles (cytokines, chemokines, growth factors, microRNAs, and exosomes) that modulate inflammation, promote tissue repair, and regulate both innate and adaptive immune responses.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immunomodulation via Paracrine Signaling by Mesenchymal Stem Cells.